As reported, mutations clustered around the ATP-binding pocket of EGFR kinase domain frequently occur in NSCLC [15, 16], and different mutation types normally correspond to diverse clinical responses to TKIs [17]. Here, EGFR is linked to non-small cell lung carcinoma.